A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether L5, one of the Low Density Lipoproteins, is an effective predicting factor for cardiovascular disease in chronic renal and hemodialytic patients.
| Condition |
|---|
|
Cardiovascular Disease Chronic Kidney Disease Patients Hemodialytic Patients High LDL Level High L5 Level |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Cross-Sectional |
| Official Title: | L5 as a Risk Factor of Cardiovascular Disease in Chronic Kidney Disease and Dialysis Patients |
Blood
| Estimated Enrollment: | 48 |
| Study Start Date: | September 2010 |
| Groups/Cohorts |
|---|
|
Normal
Healthy population
|
|
CKD Patients
Chronic Kidney Disease, in Stage III-V
|
|
HD patients
End-stage renal disease patients undergoing hemodialysis
|
Detailed Description:
Cardiovascular disease (CVD) is the most important cause of death of chronic kidney disease (CKD) and hemodialysis (HD) patients. Low Density Lipoprotein (LDL) is an essential indicator of CVD.The higher the plasma LDL level, the higher the risk of CVD. LDL is a heterogenous substance composed of different mass and size. Oxidized LDL (oxLDL) is the oxidation product of LDL and is the most important component of LDL associated with CVD. The oxLDL is mostly trapped within tissue and not easily to be detected from blood. L5 iw a kind of electronegative LDL and is associated with CVD in smokers and diabetic patients, even if these patients have normal plasma LDL. Uremia patients have lipid profile different from that of general people,while HD Patients have lower LDL and CKD patients have LDL higher than that of general population. Thus LDL plasma level cannot fully explain the high risk of CVD in CKD and HD patients. As patients with normal LDL but high L5 are prone to have CVD, we suspect there might be association of L5 with CVD in both CKD and HD patients.
Eligibility| Ages Eligible for Study: | 20 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Residents in Taiwan, mostly in Taichung area
Inclusion Criteria:
- clinical diagnosis of CKD
- clinical diagnosis of HD
Exclusion Criteria:
- N/A
Contacts and Locations| Contact: Chiz-Tzung Chang, Ph.D. | 886-4-22052121 ext 2902 | D19863@mail.cmuh.org.tw |
| Contact: Chiu-Ching Huang, MD | 886-4-22052121 ext 2902 | cch@mail.cmuh.org.tw |
| Taiwan | |
| China Medical University Hospital | Recruiting |
| Taichung City, Taiwan, 404 | |
| Contact: Chiu-Ching Huang, MD 886-4-22052121 ext 2902 cch@mail.cmuh.org.tw | |
| Contact: Chiz-Tzung Chang, MD, Ph.D. 886-4-22052121 ext 2902 D19863@mail.cmuh.org.tw | |
| Principal Investigator: Chiu-Ching Huang, MD | |
More Information
No publications provided
| Responsible Party: | Chiu-Ching Huang, China Medical University Hospital |
| ClinicalTrials.gov Identifier: | NCT01236820 History of Changes |
| Other Study ID Numbers: | CTCHANG001 |
| Study First Received: | November 5, 2010 |
| Last Updated: | November 8, 2010 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by China Medical University Hospital:
|
L5 LDL Cardiovascular disease Chronic kidney disease Hemodialysis |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Kidney Diseases Renal Insufficiency, Chronic |
Kidney Failure, Chronic Urologic Diseases Renal Insufficiency |
ClinicalTrials.gov processed this record on May 16, 2013